CAS: 2060610-53-7
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | (2R)-2-(5-Fluoro-2-hydroxyphenyl)-2-{1-oxo-6-[4-(piperazin-1-yl)phenyl]-1,3-dihydro-2H-isoindol-2-yl}-N-(1,3-thiazol-2-yl)acetamide REF: 3D-KHD61053CAS: 2060610-53-7 | Min. 95% | A consultar | Sex 20 Jun 25 |
 | JBJ-04-125-02 REF: TM-T11714CAS: 2060610-53-7 | 98% | 907,00 €~2.375,00 € | Qui 26 Jun 25 |
![(2R)-2-(5-Fluoro-2-hydroxyphenyl)-2-{1-oxo-6-[4-(piperazin-1-yl)phenyl]-1,3-dihydro-2H-isoindol-2-…](https://static.cymitquimica.com/products/3D/thumb/KHD61053.jpg)
(2R)-2-(5-Fluoro-2-hydroxyphenyl)-2-{1-oxo-6-[4-(piperazin-1-yl)phenyl]-1,3-dihydro-2H-isoindol-2-yl}-N-(1,3-thiazol-2-yl)acetamide
CAS:2060610-53-7
Please enquire for more information about (2R)-2-(5-Fluoro-2-hydroxyphenyl)-2-{1-oxo-6-[4-(piperazin-1-yl)phenyl]-1,3-dihydro-2H-isoindol-2-yl}-N-(1,3-thiazol-2-yl)acetamide including the price, delivery time and more detailed …
Fórmula:
C29H26FN5O3S
Pureza:
Min. 95%
Peso molecular:
543.6 g/mol
Ref: 3D-KHD61053
| 10mg | 1.027,00 € | ||
| 25mg | 1.674,00 € | ||
| 50mg | 2.609,00 € |
Entrega estimada em Estados Unidos, Sexta-feira 20 de Junho de 2025
JBJ-04-125-02
CAS:2060610-53-7
JBJ-04-125-02: Oral EGFR inhibitor, targets EGFRL858R/T790M with 0.26 nM IC50, halts cancer growth, anti-tumor.
Fórmula:
C29H26FN5O3S
Pureza:
98%
Cor e Forma:
Solid
Peso molecular:
543.61
Ref: TM-T11714
| 25mg | 1.444,00 € | ||
| 50mg | 1.882,00 € | ||
| 100mg | 2.375,00 € |
Entrega estimada em Estados Unidos, Quinta-feira 26 de Junho de 2025
